Your browser doesn't support javascript.
loading
Comparison of Objective Prognostic Score and Palliative Prognostic Score performance in inpatients with advanced cancer in Japan and Korea.
Hiratsuka, Yusuke; Kim, Daye; Suh, Sang-Yeon; Kim, Sun-Hyun; Yoon, Seok-Joon; Koh, Su-Jin; Park, Shin Ae; Seo, Ji-Yeon; Kwon, Jung Hye; Park, Jeanno; Park, Youngmin; Hwang, Sun Wook; Lee, Eon Sook; Choi, Hana; Ahn, Hong-Yup; Cheng, Shao-Yi; Chen, Ping-Jen; Yamaguchi, Takashi; Morita, Tatsuya; Tsuneto, Satoru; Mori, Masanori; Inoue, Akira.
Afiliação
  • Hiratsuka Y; Department of Palliative Medicine, Takeda General Hospital, Aizuwakamatsu, Japan.
  • Kim D; Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan.
  • Suh SY; Department of Family Medicine, Hospice and Palliative Care Center, Dongguk University Ilsan Hospital, Goyang, South Korea.
  • Kim SH; Department of Family Medicine, Hospice and Palliative Care Center, Dongguk University Ilsan Hospital, Goyang, South Korea.
  • Yoon SJ; Department of Medicine, Dongguk University Medical School, Seoul, South Korea.
  • Koh SJ; Department of Family Medicine, School of Medicine, Catholic Kwandong University International St. Mary's Hospital, Incheon, South Korea.
  • Park SA; Department of Family Medicine, Chungnam National University Hospital, Daejeon, South Korea.
  • Seo JY; Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, South Korea.
  • Kwon JH; Department of Family Medicine, Hospice and Palliative Care Center, Seobuk Hospital, Seoul Metropolitan Government, Seoul, South Korea.
  • Park J; Department of Family Medicine, Hospice and Palliative Care Center, Seobuk Hospital, Seoul Metropolitan Government, Seoul, South Korea.
  • Park Y; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, South Korea.
  • Hwang SW; Department of Internal Medicine, Bobath Hospital, Seongnam, South Korea.
  • Lee ES; Department of Family Medicine, Hospice and Palliative Care Center, National Health Insurance Service Ilsan Hospital, Goyang, South Korea.
  • Choi H; Department of Family Medicine, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
  • Ahn HY; Department of Family Medicine, Ilsan-Paik Hospital, College of Medicine, Inje University, Goyang, South Korea.
  • Cheng SY; Department of Statistics, Dongguk University, Seoul, South Korea.
  • Chen PJ; Department of Statistics, Dongguk University, Seoul, South Korea.
  • Yamaguchi T; Department of Family Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan.
  • Morita T; Department of Family Medicine, Kaohsiung Medical University Hospital, and School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Tsuneto S; Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London, London, UK.
  • Mori M; Division of Palliative Care, Konan Medical Center, Kobe, Japan.
  • Inoue A; Division of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Palliat Support Care ; 20(5): 662-670, 2022 10.
Article em En | MEDLINE | ID: mdl-36111731
ABSTRACT

OBJECTIVE:

Accurate prognostication is important for patients and their families to prepare for the end of life. Objective Prognostic Score (OPS) is an easy-to-use tool that does not require the clinicians' prediction of survival (CPS), whereas Palliative Prognostic Score (PaP) needs CPS. Thus, inexperienced clinicians may hesitate to use PaP. We aimed to evaluate the accuracy of OPS compared with PaP in inpatients in palliative care units (PCUs) in three East Asian countries.

METHOD:

This study was a secondary analysis of a cross-cultural, multicenter cohort study. We enrolled inpatients with far-advanced cancer in PCUs in Japan, Korea, and Taiwan from 2017 to 2018. We calculated the area under the receiver operating characteristics (AUROC) curve to compare the accuracy of OPS and PaP.

RESULTS:

A total of 1,628 inpatients in 33 PCUs in Japan and Korea were analyzed. OPS and PaP were calculated in 71.7% of the Japanese patients and 80.0% of the Korean patients. In Taiwan, PaP was calculated for 81.6% of the patients. The AUROC for 3-week survival was 0.74 for OPS in Japan, 0.68 for OPS in Korea, 0.80 for PaP in Japan, and 0.73 for PaP in Korea. The AUROC for 30-day survival was 0.70 for OPS in Japan, 0.71 for OPS in Korea, 0.79 for PaP in Japan, and 0.74 for PaP in Korea. SIGNIFICANCE OF

RESULTS:

Both OPS and PaP showed good performance in Japan and Korea. Compared with PaP, OPS could be more useful for inexperienced physicians who hesitate to estimate CPS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Palliat Support Care Assunto da revista: TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Palliat Support Care Assunto da revista: TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão